Campath Interactions
There are 485 drugs known to interact with Campath (alemtuzumab), along with 3 disease interactions. Of the total drug interactions, 327 are major, and 158 are moderate.
- View all 485 medications that may interact with Campath
- View Campath disease interactions (3)
Most frequently checked interactions
View interaction reports for Campath (alemtuzumab) and the medicines listed below.
- acetaminophen
- acyclovir
- amitriptyline
- amlodipine
- amoxicillin / clavulanate
- Ampyra (dalfampridine)
- Aranesp (darbepoetin alfa)
- baclofen
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- betaine
- Braftovi (encorafenib)
- bupropion
- CellCept (mycophenolate mofetil)
- clonazepam
- Cytosar (cytarabine)
- Decadron (dexamethasone)
- Dialyvite (multivitamin with iron)
- dicyclomine
- Diflucan (fluconazole)
- doxylamine
- Eloxatin (oxaliplatin)
- Epogen (epoetin alfa)
- Erbitux (cetuximab)
- fexofenadine
- gabapentin
- naproxen
- topiramate
- Valium (diazepam)
- venlafaxine
Campath disease interactions
There are 3 disease interactions with Campath (alemtuzumab) which include:
Report options
More about Campath (alemtuzumab)
- Campath consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD52 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Rituxan
Rituxan is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Ibrutinib
Ibrutinib (Imbruvica) is a Bruton's tyrosine kinase inhibitor used for certain blood cancers and ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.